2018
DOI: 10.15407/ubj90.05.091
|View full text |Cite
|
Sign up to set email alerts
|

The indices of nitrogen (II) oxide system in experimental hepatopulmonary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 26 publications
0
4
0
2
Order By: Relevance
“…;Polyauk et al 2017). However, methods are not developed for examination of captopril from Caco-2 cell monolayers (Fujikawa et al 2005;Gertz et al 2010;Krynytska et al 2018). Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compounds.…”
Section: Introductionmentioning
confidence: 99%
“…;Polyauk et al 2017). However, methods are not developed for examination of captopril from Caco-2 cell monolayers (Fujikawa et al 2005;Gertz et al 2010;Krynytska et al 2018). Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compounds.…”
Section: Introductionmentioning
confidence: 99%
“…In a similar study, Degano et al found that concentration of NO in exhaled air of patients with cirrhosis was three times higher than that in healthy persons 14 . Krynytska and Marushchak found a significant increase in total NOS activity and concentration of NO 2-+ NO 3in lung tissue of rats with HPS 15 . Using flow cytometry, which allowed to differentiate the alveolar and bronchial origin of NO, it was determined that the increased formation of NO mainly took place in the alveoli 16 .…”
Section: Nitric Oxide-mediated Vasodilationmentioning
confidence: 93%
“…The hepatopulmonary syndrome (HPS) is an important vascular complication because of systemic hypoxemia in patients with cirrhosis and/or portal hypertension. It is formed by a clinical triad of arterial oxygenation abnormalities induced by intrapulmonary vascular dilatations with liver disease [1][2][3] . True HPS is estimated to occur in at least 10% of all patients with cirrhosis and portal hypertension 4 .…”
Section: Introductionmentioning
confidence: 99%